Literature DB >> 11241128

Vein adaptation to arterialization in an experimental model.

A Westerband1, D Crouse, L C Richter, M L Aguirre, C C Wixon, D C James, J L Mills, G C Hunter, R L Heimark.   

Abstract

PURPOSE: The events preceding myointimal thickening in vein grafts after vascular reconstructions are not well characterized. Indeed, the injury response associated with vein graft arterialization may be different than that observed in the balloon angioplasty model. Therefore, we used a rat model to study the early cellular response after arterialization of vein grafts.
METHODS: Epigastric veins were placed as femoral artery interposition grafts in 37 male Lewis rats (weight range, 350-400 g). Vein grafts and contralateral epigastric veins were harvested at different time points (6 hours, 1 day, 2 days, 3 days, 7 days, 14 days, 21 days, 30 days, and 70 days). Tissue specimens were processed for histology and immunohistochemistry with antibodies for the proliferating cell nuclear antigen (PCNA) and for different cell types. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay was used as a means of determining the presence of apoptosis. Electron microscopy was used as means of assessing the integrity of the endothelial cell surface (SEM) and confirming the presence of apoptosis (TEM). Specimens were also snap frozen in liquid nitrogen for RNA isolation and molecular analysis.
RESULTS: At 1 day, endothelial denudation with platelet deposition on the surface was shown by means of SEM. Both apoptosis and necrosis of smooth muscle cells (SMCs) were present in the media, along with monocyte infiltration. Cellular proliferation and apoptosis were most intense within the first week of implantation. PCNA staining was first seen in the adventitial fibroblasts and microvessels, then in the medial SMCs at 3 days. With reverse transcriptase polymerase chain reaction, upregulation of vascular endothelial growth factor (VEGF) messenger RNA (mRNA) was noted at 1 day. Myointimal thickening progressively developed, with no apparent diminution of the luminal area as long as 70 days after implantation. By means of the analysis of the transforming growth factor beta1, mRNA showed expression during intimal thickening and accumulation of extracellular matrix. Reendothelialization was complete at 30 days.
CONCLUSIONS: These observations indicate that the cellular composition in our vein graft model is similar to human stenotic explants. Endothelial denudation is observed in rat vein grafts with complete regeneration by 30 days. VEGF mRNA is upregulated at 1 day, followed by proliferation of microvessel endothelial cells in the adventitia. Cellular proliferation and apoptosis are minimal after 21 days, with progressive intimal thickening likely to be the result of matrix accumulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241128     DOI: 10.1067/mva.2001.112230

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

1.  Apoptosis, cell proliferation and modulation of cyclin-dependent kinase inhibitor p21(cip1) in vascular remodelling during vein arterialization in the rat.

Authors:  Thaiz Ferraz Borin; Ayumi Aurea Miyakawa; Leandro Cardoso; Luciano de Figueiredo Borges; Giovana Aparecida Gonçalves; Jose Eduardo Krieger
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

2.  Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts.

Authors:  Atsunori Nakao; Chien-Sheng Huang; Donna B Stolz; Yinna Wang; Jonathan M Franks; Naobumi Tochigi; Timothy R Billiar; Yoshiya Toyoda; Edith Tzeng; Kenneth R McCurry
Journal:  Cardiovasc Res       Date:  2010-09-16       Impact factor: 10.787

Review 3.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

Review 4.  Vein graft failure: from pathophysiology to clinical outcomes.

Authors:  Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2016-05-19       Impact factor: 32.419

Review 5.  Membrane-mediated regulation of vascular identity.

Authors:  Takuya Hashimoto; Masayuki Tsuneki; Trenton R Foster; Jeans M Santana; Hualong Bai; Mo Wang; Haidi Hu; Jesse J Hanisch; Alan Dardik
Journal:  Birth Defects Res C Embryo Today       Date:  2016-03-17

6.  Early adaptive responses of the vascular wall during venous arterialization in mice.

Authors:  Stephanie Kwei; George Stavrakis; Masaya Takahas; George Taylor; M Judah Folkman; Michael A Gimbrone; Guillermo García-Cardeña
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

7.  Flow increase is decisive to initiate angiogenesis in veins exposed to altered hemodynamics.

Authors:  Volker J Schmidt; Johannes G Hilgert; Jennifer M Covi; Nico Leibig; Johanna O Wietbrock; Andreas Arkudas; Elias Polykandriotis; Cor de Wit; Raymund E Horch; Ulrich Kneser
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

8.  Flow Induced Microvascular Network Formation of Therapeutic Relevant Arteriovenous (AV) Loop-Based Constructs in Response to Ionizing Radiation.

Authors:  Volker J Schmidt; Jennifer M Covi; Christoph Koepple; Johannes G Hilgert; Elias Polykandriotis; Amir K Bigdeli; Luitpold V Distel; Raymund E Horch; Ulrich Kneser
Journal:  Med Sci Monit       Date:  2017-02-15

9.  Contribution of endothelial injury and inflammation in early phase to vein graft failure: the causal factors impact on the development of intimal hyperplasia in murine models.

Authors:  Chi-Nan Tseng; Eva Karlöf; Ya-Ting Chang; Mariette Lengquist; Pierre Rotzius; Per-Olof Berggren; Ulf Hedin; Einar E Eriksson
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

Review 10.  Inflammation in Vein Graft Disease.

Authors:  Margreet R de Vries; Paul H A Quax
Journal:  Front Cardiovasc Med       Date:  2018-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.